Patents by Inventor Kenneth Cundy

Kenneth Cundy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
    Publication number: 20070015716
    Abstract: Disclosed are methods for providing enhanced systemic blood concentrations of orally delivered drugs that are incompletely translocated across the intestinal wall of an animal. Also disclosed are methods for the sustained release of drugs, whether poorly or readily bioavailable via oral delivery to animals. Still further, disclosed are compounds and pharmaceutical compositions that are used in such methods.
    Type: Application
    Filed: July 11, 2006
    Publication date: January 18, 2007
    Inventors: Mark Gallop, Kenneth Cundy
  • Prodrugs of GABA analogs, compositions and uses thereof
    Publication number: 20070010453
    Abstract: The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.
    Type: Application
    Filed: May 22, 2006
    Publication date: January 11, 2007
    Inventors: Mark Gallop, Kenneth Cundy, Cindy Zhou, Fayang Qiu, Fenmei Yao, Jia-Ning Xiang, Ian Ollmann
  • Prodrugs of GABA analogs, compositions and uses thereof
    Publication number: 20060229361
    Abstract: The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.
    Type: Application
    Filed: April 6, 2005
    Publication date: October 12, 2006
    Inventors: Mark Gallop, Kenneth Cundy, Cindy Zhou, Fenmei Yao, Jia-Ning Xiang, Ian Ollman, Fayang Qiu
  • Bile-acid conjugates providing for sustained systemic concentration of drugs
    Publication number: 20060166858
    Abstract: This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed to pharmaceutical compositions including and methods using such compounds.
    Type: Application
    Filed: March 24, 2006
    Publication date: July 27, 2006
    Applicant: XenoPort, Inc.
    Inventors: Kenneth Cundy, Mark Gallop, Cindy Zhou
  • GABA analog prodrug sustained release oral dosage forms
    Publication number: 20060141034
    Abstract: Sustained release oral dosage forms of a gabapentin prodrug, 1-{[(?-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective.
    Type: Application
    Filed: November 3, 2005
    Publication date: June 29, 2006
    Inventors: Kenneth Cundy, Srikonda Sastry, Manshiu Leung, Balaji Kadri, Paul Stach
  • Levodopa prodrugs, and compositions and uses thereof
    Publication number: 20060020028
    Abstract: Prodrugs of levodopa, methods of making prodrugs of levodopa, methods of using prodrugs of levodopa, and compositions of prodrugs of levodopa are disclosed.
    Type: Application
    Filed: June 3, 2005
    Publication date: January 26, 2006
    Inventors: Jia-Ning Xiang, Mark Gallop, Cindy Zhou, Mark Nguyen, Xuedong Dai, Jianhua Li, Kenneth Cundy
  • Bile-acid conjugates for providing sustained systemic concentrations of drugs
    Publication number: 20050288228
    Abstract: This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed to pharmaceutical compositions including and methods using such compounds.
    Type: Application
    Filed: September 6, 2005
    Publication date: December 29, 2005
    Inventors: Kenneth Cundy, Mark Gallop
  • Levodopa prodrugs, and compositions and uses thereof
    Publication number: 20050282891
    Abstract: Prodrugs of levodopa, methods of making prodrugs of levodopa, methods of using prodrugs of levodopa, and compositions of prodrugs of levodopa are disclosed.
    Type: Application
    Filed: June 3, 2005
    Publication date: December 22, 2005
    Inventors: Jia-Ning Xiang, Mark Gallop, Cindy Zhou, Mark Nguyen, Xuedong Dai, Jianhua Li, Kenneth Cundy, Nelson Jumbe
  • Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
    Publication number: 20050272710
    Abstract: This invention is directed to methods for providing sustained systemic concentrations of therapeutic or prophylactic agents such as GABA analogs following oral administration to animals. This invention is also directed to compounds and pharmaceutical compositions that are used in such methods.
    Type: Application
    Filed: July 19, 2005
    Publication date: December 8, 2005
    Applicant: XenoPort, Inc.
    Inventors: Kenneth Cundy, Mark Gallop, Cindy Zhou
  • Treatment of local pain
    Publication number: 20050209319
    Abstract: Methods and compositions for treating or preventing local pain or discomfort, particularly local neuropathic pain via topical application directly to skin or mucosal tissue at the site of pain or discomfort are disclosed. Compositions comprising prodrugs of gamma amino butyric acid analogs, such as prodrugs of gabapentin or pregabalin, and optionally a topical anesthetic agent are also disclosed.
    Type: Application
    Filed: March 15, 2005
    Publication date: September 22, 2005
    Applicant: XenoPort, Inc.
    Inventor: Kenneth Cundy
  • Bile-acid conjugates providing for sustained systemic concentration of drugs
    Publication number: 20050148564
    Abstract: This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed to pharmaceutical compositions including and methods using such compounds.
    Type: Application
    Filed: February 9, 2005
    Publication date: July 7, 2005
    Applicant: XenoPort, Inc.
    Inventors: Kenneth Cundy, Mark Gallop, Cindy Zhou
  • Compounds for sustained release of orally delivered drugs
    Publication number: 20050054559
    Abstract: Disclosed are methods for providing sustained systemic blood concentrations of orally delivered drugs. Still further, disclosed are compounds and pharmaceutical compositions that are used in such methods.
    Type: Application
    Filed: July 7, 2004
    Publication date: March 10, 2005
    Inventors: Mark Gallop, Kenneth Cundy
  • Amino acid derived prodrugs of propofol, compositions and uses thereof
    Publication number: 20050004381
    Abstract: The present invention provides propofol prodrugs, methods of making propofol prodrugs, pharmaceutical compositions of propofol prodrugs and methods of using propofol prodrugs and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as migraine headache pain and post-chemotherapy or post-operative surgery nausea and vomiting.
    Type: Application
    Filed: January 28, 2004
    Publication date: January 6, 2005
    Inventors: Mark Gallop, Feng Xu, Kenneth Cundy, Vivek Sasikumar, Thomas Woiwode